Back to Journals » Open Access Surgery » Volume 6

Effects of rosiglitazone pretreatment on blood glucose, lipid levels, urea, and microalbuminuria in rats undergoing 70% pancreatectomy

Authors Acar, Senel OO, Bukan, Yürekli, Salman, Yetisir F

Received 19 October 2012

Accepted for publication 17 November 2012

Published 4 January 2013 Volume 2013:6 Pages 1—5

DOI https://doi.org/10.2147/OAS.S39364

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 4

Hasan Zafe Acar,1 Oytun Okan Senel,2 Neslihan Bukan,3 Banu Yurekli,4 A Ebru Salman,5 Fahri Yetisir6

1Yozgat Bozok University Hospital, General Surgery Department, Yozgat, 2Department of Surgery, Faculty of Veterinary Medicine, Ankara University, Ankara, 3Department of Medical Biochemistry, Gazi University, Ankara, 4Department of Endocrinology, Bozyaka Research and Training Hospital, Izmir, 5Department of Anesthesiology and Reanimation, 6Department of General Surgery, Ataturk Research and Training Hospital, Ankara, Turkey

Background: Partial pancreatectomy is one of the main causes of type II diabetes, which occurs because of insulin deficiency due to a decrease in the number of β-cells. Partial pancreatectomy is the treatment of choice particularly for pancreatic cysts, benign and malign tumors of the pancreas, and pancreatic abscesses. Morbidity and mortality associated with pancreatectomy increases as a result of diabetes and its complications.
Purpose: This experimental study was designed to investigate the effects of rosiglitazone pretreatment on blood glucose, lipid, urea, and microalbuminuria levels in rats undergoing 70% pancreatectomy.
Material and methods: Twelve Wistar albino rats weighing 180–230 g were randomized into two groups. The study group (n = 6) received rosiglitazone (10 mg/kg/day) orally for 4 weeks before and after pancreatectomy. The control group (n = 6) received vehicle. At the end of the fourth week, all rats underwent pancreatectomy, which was performed by removing 70% of their pancreatic tissue. Blood samples were taken from the tail veins at postoperative day one, week two, and week four for analysis of blood glucose, triglyceride, cholesterol, and urea levels. Urine was collected from the bladder for microalbuminuria analysis.
Results: Blood glucose levels in the study group were significantly lower than the control group at postoperative day one, week two, week four (P = 0.01, P = 0.004, and P = 0.005, respectively). Significant microalbuminuria was present at postoperative week four when compared to the control group (P < 0.05). Triglyceride, cholesterol, and urea levels were within normal limits.
Conclusion: This study showed that pretreatment of rosiglitazone increased the tolerance to diabetes in rats undergoing partial pancreatectomy.

Keywords: rosiglitazone, partial pancreatectomy, diabetes

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Other article by this author:

Readers of this article also read:

Emerging and future therapies for hemophilia

Carr ME, Tortella BJ

Journal of Blood Medicine 2015, 6:245-255

Published Date: 3 September 2015

Comparative efficacy and safety of local and systemic methotrexate injection in cesarean scar pregnancy

Peng P, Gui T, Liu X, Chen W, Liu Z

Therapeutics and Clinical Risk Management 2015, 11:137-142

Published Date: 27 January 2015

Is increasing the dose of Entecavir effective in partial virological responders?

Erturk A, Adnan Akdogan R, Parlak E, Cure E, Cumhur Cure M, Ozturk C

Drug Design, Development and Therapy 2014, 8:621-625

Published Date: 29 May 2014

Profile of imatinib in pediatric leukemia

Burke MJ

Pediatric Health, Medicine and Therapeutics 2014, 5:1-7

Published Date: 3 February 2014